Anne Helfen1, Nils Große Hokamp2, Christiane Geyer1,3, Walter Heindel1, Christoph Bremer4, Thomas Vogl5, Carsten Höltke1, Max Masthoff1, Katarzyna Barczyk-Kahlert5, Johannes Roth5, Moritz Wildgruber1, Michel Eisenblaetter6,7. 1. Translational Research Imaging Center, Institute of Clinical Radiology, Medical Faculty, University of Muenster and University Hospital Muenster, Muenster, Germany. 2. Institute for Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany. 3. Interdisciplinary Center for Clinical Research, University of Muenster, Muenster, Germany. 4. Department of Radiology, St Franziskus Hospital Muenster, Muenster, Germany. 5. Institute of Immunology, University Hospital Muenster, Muenster, Germany. 6. Translational Research Imaging Center, Institute of Clinical Radiology, Medical Faculty, University of Muenster and University Hospital Muenster, Muenster, Germany. eisenblaetter@uni-muenster.de. 7. Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Freiburg, Germany. eisenblaetter@uni-muenster.de.
Abstract
PURPOSE: Tumor development and metastasis are dependent on tumor infiltrating immune cells which form a characteristic tumor microenvironment (TME). Activated monocytes secrete the protein heterodimer S100A8/A9 promoting TME formation. Monocyte-dependent proteases facilitate local tumor cell invasion by degradation of the extracellular matrix. We aimed for target specific in vivo imaging of S100A8 and proteases to provide differentiating biomarkers for local tumor growth and metastatic potential. PROCEDURES: Murine breast cancer cells of the 4T1 model with graduated metastatic potential (4T1 and 4T07: both hematogenous metastasis > 168FAR: lymph-node metastasis > 67NR: no metastasis) were orthotopically implanted into female BALB/c mice. At 4 mm size, tumors were investigated by injecting the protease-specific probe ProSense 750EX (PerkinElmer, 4T1 n = 7, 4T07 n = 10, 168FAR n = 16, 67NR n = 15) and anti-S100A8-Cy5.5 (n = 6 each) and performing fluorescence reflectance imaging at 0 and 24 h after injection. In vivo imaging was validated with immunohistochemistry. RESULTS: At 24 h, S100A8-specific signals in 4T1 and 4T07 were significantly higher (1714.05/1683.45 AU) as compared to 168FAR and 67NR (174.85/167.95 AU, p = 0.0012/p = 0.0003), reflecting the capability of hematogenous spread. Protease-specific signals were significantly higher in 4T1 and 4T07 (348.01/409.93 AU) as compared to 168FAR (214.91 AU) and 67NR (129.78 AU p < 0.0001 each), reflecting local vessel invasion and tumor cell shedding. Immunohistology supported the in vivo imaging results. CONCLUSIONS: Non-invasive in vivo imaging of S100A8 and monocytic proteases allows for differentiation of the tumors' local invasive and systemic metastatic potential in reflecting the TME formation. While proteases augment local tumor cell invasion, solid metastases seem to be dependent on a pro-tumoral microenvironment.
PURPOSE:Tumor development and metastasis are dependent on tumor infiltrating immune cells which form a characteristic tumor microenvironment (TME). Activated monocytes secrete the protein heterodimer S100A8/A9 promoting TME formation. Monocyte-dependent proteases facilitate local tumor cell invasion by degradation of the extracellular matrix. We aimed for target specific in vivo imaging of S100A8 and proteases to provide differentiating biomarkers for local tumor growth and metastatic potential. PROCEDURES: Murinebreast cancer cells of the 4T1 model with graduated metastatic potential (4T1 and 4T07: both hematogenous metastasis > 168FAR: lymph-node metastasis > 67NR: no metastasis) were orthotopically implanted into female BALB/c mice. At 4 mm size, tumors were investigated by injecting the protease-specific probe ProSense 750EX (PerkinElmer, 4T1 n = 7, 4T07 n = 10, 168FAR n = 16, 67NR n = 15) and anti-S100A8-Cy5.5 (n = 6 each) and performing fluorescence reflectance imaging at 0 and 24 h after injection. In vivo imaging was validated with immunohistochemistry. RESULTS: At 24 h, S100A8-specific signals in 4T1 and 4T07 were significantly higher (1714.05/1683.45 AU) as compared to 168FAR and 67NR (174.85/167.95 AU, p = 0.0012/p = 0.0003), reflecting the capability of hematogenous spread. Protease-specific signals were significantly higher in 4T1 and 4T07 (348.01/409.93 AU) as compared to 168FAR (214.91 AU) and 67NR (129.78 AU p < 0.0001 each), reflecting local vessel invasion and tumor cell shedding. Immunohistology supported the in vivo imaging results. CONCLUSIONS: Non-invasive in vivo imaging of S100A8 and monocytic proteases allows for differentiation of the tumors' local invasive and systemic metastatic potential in reflecting the TME formation. While proteases augment local tumor cell invasion, solid metastases seem to be dependent on a pro-tumoral microenvironment.
Entities:
Keywords:
Breast neoplasms; Molecular imaging; Tumor escape; Tumor microenvironment
Authors: Matthias Nahrendorf; David E Sosnovik; Peter Waterman; Filip K Swirski; Ashvin N Pande; Elena Aikawa; Jose-Luiz Figueiredo; Mikael J Pittet; Ralph Weissleder Journal: Circ Res Date: 2007-03-22 Impact factor: 17.367
Authors: Anne Becker; Nils Große Hokamp; Stefanie Zenker; Fabian Flores-Borja; Katarzyna Barzcyk; Georg Varga; Johannes Roth; Christiane Geyer; Walter Heindel; Christoph Bremer; Thomas Vogl; Michel Eisenblaetter Journal: J Nucl Med Date: 2015-02-12 Impact factor: 10.057
Authors: Michel Eisenblaetter; Fabian Flores-Borja; Jae Jin Lee; Christina Wefers; Hannah Smith; Rebekka Hueting; Margaret S Cooper; Philip J Blower; Dominic Patel; Manuel Rodriguez-Justo; Hanna Milewicz; Thomas Vogl; Johannes Roth; Andrew Tutt; Tobias Schaeffter; Tony Ng Journal: Theranostics Date: 2017-06-15 Impact factor: 11.556
Authors: Luis de la Cruz-Merino; Antonio Barco-Sánchez; Fernando Henao Carrasco; Esteban Nogales Fernández; Ana Vallejo Benítez; Javier Brugal Molina; Antonio Martínez Peinado; Ana Grueso López; Manuel Ruiz Borrego; Manuel Codes Manuel de Villena; Víctor Sánchez-Margalet; Adoración Nieto-García; Emilio Alba Conejo; Noelia Casares Lagar; José Ibáñez Martínez Journal: Clin Dev Immunol Date: 2013-06-03